tiprankstipranks
Trending News
More News >
Nirvana Life Sciences Inc (TSE:NIRV)
:NIRV
Canadian Market

Nirvana Life Sciences Inc (NIRV) Income Statement

Compare
6 Followers

Nirvana Life Sciences Inc Income Statement

Last quarter (Q1 2025), Nirvana Life Sciences Inc's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, Nirvana Life Sciences Inc's net income was C$-36.41K. See Nirvana Life Sciences Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating Expenses
C$ 339.94K-C$ 1.18MC$ 314.24KC$ 74.83K
Depreciation and Amortization
C$ 18.31KC$ 91.64KC$ 91.64K-C$ 171.86K
EBITDA
C$ -321.63K-C$ 3.40MC$ -314.24KC$ -74.53K
Operating Income
C$ -339.94K-C$ -859.12KC$ -314.24KC$ -74.53K
Other Income/Expenses
C$ -25.98K-C$ -4.49M-C$ 91.09K
Pretax Income
C$ -365.92K-C$ -5.66MC$ -314.24KC$ 13.31K
Net Income
C$ -365.92K-C$ -5.65MC$ -314.24KC$ 13.31K
Per Share Metrics
Basic EPS
C$ -0.08C$ 0.00C$ -0.15C$ -0.01C$ 0.00
Diluted EPS
C$ -0.08C$ 0.00C$ -0.15C$ -0.01C$ 0.00
Weighted Average Shares Outstanding
4.82M 17.04M 36.52M 33.02M 33.02M
Weighted Average Shares Outstanding (Diluted)
4.82M 17.04M 36.52M 33.02M 33.02M
Currency in CAD

Nirvana Life Sciences Inc Earnings and Revenue History